Company profile: Tela Bio
1.1 - Company Overview
Company description
- Provider of soft tissue reconstruction solutions, including OviTex Reinforced Tissue Matrix, a surgical mesh combining ovine rumen and polymer suture for soft tissue repair; OviTex PRS, a biologic mesh reinforced for plastic and reconstructive surgery; LIQUIFIX Atraumatic Mesh Fixation, a liquid adhesive for hernia mesh and tissue fixation designed to reduce post-operative complications; and OviTex IHR for inguinal hernia repair.
Products and services
- LIQUIFIX Atraumatic Mesh Fixation: A liquid adhesive device for mesh and tissue fixation in hernia repair, engineered to reduce post-operative complications, offering atraumatic fixation
- OviTex PRS Reinforced Tissue Matrix: A biologic mesh reinforced with polymer suture for plastic and reconstructive surgery, engineered for tissue remodeling
- OviTex Reinforced Tissue Matrix: A surgical mesh made from ovine rumen and polymer suture engineered for soft tissue repair, leveraging natural healing with reinforced matrix
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Tela Bio
Valencia Technologies
HQ: United States
Website
- Description: Provider of implantable neuromodulation solutions for urge urinary incontinence, including eCoin, a coin-sized neurostimulator implanted subcutaneously in the lower leg that delivers automatic intermittent tibial nerve stimulation to reduce symptoms, and the eCoin Physician Qualification training program to certify physicians to offer eCoin therapy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Valencia Technologies company profile →
BioDerm
HQ: United States
Website
- Description: Provider of urine management, infection control, and catheter securement solutions based on hydrocolloid technology that seals securely to skin to protect from moisture and bacteria. Offerings include Men’s Liberty male external catheters (acute and home), UriCap Female urine collection system, CathGrip tubing securement, Kind Klamp for temporary urine flow control, and BioPlus+ skin prep wipes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioDerm company profile →
Halt Medical
HQ: United States
Website
- Description: Provider of a uterine fibroid device that enables removal of uterine fibroids without resorting to hysterectomy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Halt Medical company profile →
Andromeda Medizinische Systeme
HQ: Germany
Website
- Description: Provider of modern, high-quality urodynamic instruments, developed and marketed by ANDROMEDA medizin Systeme GmbH, founded in 1994 and recognized as a specialist, pioneer, and one of the world's leading manufacturers in urodynamics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Andromeda Medizinische Systeme company profile →
American Medical Systems
HQ: United States
Website
- Description: Provider of diversified medical devices and procedures to treat incontinence, erectile dysfunction, benign prostatic hyperplasia (BPH), pelvic floor prolapse, and other pelvic disorders in men and women; a wholly owned subsidiary of Endo Pharmaceutical headquartered in Minnetonka, Minnesota.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full American Medical Systems company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Tela Bio
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Tela Bio
2.2 - Growth funds investing in similar companies to Tela Bio
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Tela Bio
4.2 - Public trading comparable groups for Tela Bio
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →